Microfluidic platform for electrophysiological recordings from host-stage hookworm and Ascaris suum larvae: A new tool for anthelmintic research

Int J Parasitol Drugs Drug Resist. 2016 Dec;6(3):314-328. doi: 10.1016/j.ijpddr.2016.08.001. Epub 2016 Sep 15.

Abstract

The screening of candidate compounds and natural products for anthelmintic activity is important for discovering new drugs against human and animal parasites. We previously validated in Caenorhabditis elegans a microfluidic device ('chip') that records non-invasively the tiny electrophysiological signals generated by rhythmic contraction (pumping) of the worm's pharynx. These electropharyngeograms (EPGs) are recorded simultaneously from multiple worms per chip, providing a medium-throughput readout of muscular and neural activity that is especially useful for compounds targeting neurotransmitter receptors and ion channels. Microfluidic technologies have transformed C. elegans research and the goal of the current study was to validate hookworm and Ascaris suum host-stage larvae in the microfluidic EPG platform. Ancylostoma ceylanicum and A. caninum infective L3s (iL3s) that had been activated in vitro generally produced erratic EPG activity under the conditions tested. In contrast, A. ceylanicum L4s recovered from hamsters exhibited robust, sustained EPG activity, consisting of three waveforms: (1) conventional pumps as seen in other nematodes; (2) rapid voltage deflections, associated with irregular contractions of the esophagus and openings of the esophogeal-intestinal valve (termed a 'flutter'); and (3) hybrid waveforms, which we classified as pumps. For data analysis, pumps and flutters were combined and termed EPG 'events.' EPG waveform identification and analysis were performed semi-automatically using custom-designed software. The neuromodulator serotonin (5-hydroxytryptamine; 5HT) increased EPG event frequency in A. ceylanicum L4s at an optimal concentration of 0.5 mM. The anthelmintic drug ivermectin (IVM) inhibited EPG activity in a concentration-dependent manner. EPGs from A. suum L3s recovered from pig lungs exhibited robust pharyngeal pumping in 1 mM 5HT, which was inhibited by IVM. These experiments validate the use of A. ceylanicum L4s and A. suum L3s with the microfluidic EPG platform, providing a new tool for screening anthelmintic candidates or investigating parasitic nematode feeding behavior.

Keywords: Ancylostoma; Anthelmintic; Ascaris; Electropharyngeogram; Electrophysiology; Hookworm; Ivermectin; Microfluidic; ScreenChip; Serotonin.

Publication types

  • Validation Study

MeSH terms

  • Ancylostoma / drug effects
  • Ancylostoma / physiology*
  • Animals
  • Anthelmintics / pharmacology*
  • Ascaris suum / drug effects
  • Ascaris suum / physiology*
  • Drug Evaluation, Preclinical / methods*
  • Electrophysiological Phenomena / drug effects*
  • Larva / drug effects
  • Larva / physiology
  • Microfluidics / methods*
  • Parasitology / methods

Substances

  • Anthelmintics